A major new study has identified 2085 excess deaths in England and Wales due to heart disease and stroke during the peak of the COVID-19 pandemic. On average, that is 17 deaths each day over four months that probably could have been prevented.

29 Sep 2020

Study: HRT prescription rates are lower in more deprived areas of England

Prescription rates for hormone replacement therapy (HRT) are lower in more deprived areas of England compared to affluent areas, a new study from the University of Warwick has found.

29 Sep 2020

ACD study underscores the prevalence of malnutrition among obese individuals

A new editorial accompanying a study published in the Journal of the American College of Cardiology is bringing attention to the underappreciated and often overlooked issue of malnutrition among those who are obese.

29 Sep 2020

Study pinpoints heating element in vaping devices as cause for lung injuries

Early results of an experimental vaping study have shown significant lung injury from E-cigarette (eC) devices with nickel-chromium alloy heating elements.

28 Sep 2020

Research reveals how genetic differences in body fat affect men and women's health risks

New research is revealing how genetic differences in the fat in men's and women's bodies affect the diseases each sex is likely to get.

28 Sep 2020

Study shows clear links between genetic predisposition of CVD and lifestyle factors

From Weight Watchers to wearable tech – wherever we look, there are messages encouraging us to stay fit and healthy.

28 Sep 2020

Newer Type 2 diabetes medications could reduce kidney, heart disease risks

Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.

28 Sep 2020

Study may explain why hormone therapy slows progression of heart disease

As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis.

28 Sep 2020

Risk factors for mortality among hospitalized patients with COVID-19

A new study by scientists at biotechnology company Genentech, Inc., and published on the preprint server medRxiv in September 2020 attempts to identify the factors which may shape the risk for death in COVID-19 disease.

27 Sep 2020

Study reveals the differences in non-COVID-19 hospital admissions during rebound period

While declines in U.S. hospital admissions during the onset of COVID-19 has been well-documented, little is known about how admissions during the rebound varied by age, insurance coverage and socioeconomic groups.

26 Sep 2020

New study links 160 genes to brain shrinkage

A new study implicates 160 genes in brain shrinkage seen on MRIs of 45,000 healthy adults. The shrinkage is in the cortex, the dimply outer layer of the brain that gives rise to thinking, awareness and action, and largely consists of gray matter.

25 Sep 2020

Pitt team receives NIH award to optimize tissue-engineered vascular graft design

Just as a climbing plant needs the right trellis to thrive, a small-diameter tissue-engineered vascular graft (TEVG) needs the right scaffold to transform seeded cells into a native-like artery that can save a life.

25 Sep 2020

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.

25 Sep 2020

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

25 Sep 2020

Novel technique helps detect heart damage in top-level competition dogs

Frequent high-intensity exercise entails cardiac remodelling both in humans and animals. In dogs, especially those used for top-level competition, it is of great interest to learn whether they develop the so-called athletic heart syndrome.

25 Sep 2020

Social inequities in Black and South Asian immigrants increase risk of severe COVID-19 infection

Black, South Asian and Aboriginal populations from disadvantaged socioeconomic backgrounds in Canada are nearly four times more likely to have three or more medical conditions that have been identified as risk factors for severe illness from COVID-19.

25 Sep 2020

Study assesses cardiovascular and renal outcomes for ertugliflozin in patients with type 2 diabetes

A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels

25 Sep 2020

Study highlights the importance of healthy placental development in pregnancy

The first stages of placental development take place days before the embryo starts to form in human pregnancies. The finding highlights the importance of healthy placental development in pregnancy, and could lead to future improvements in fertility treatments such as IVF, and a better understanding of placental-related diseases in pregnancy.

25 Sep 2020

Scientists develop single-cell atlas of the normal human heart

Scientists have for the first time documenting all of the different cell types and genes expressed in the healthy human heart, in new research published in the journal Nature.

25 Sep 2020